Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 2 from your keywords: author="Caroline Nadia"
cover
Immunogenicity Validation of Predicted HLA Class II-binding Peptides Derived …
Comment Share
Caroline Nadia

SARS-CoV-2, the cause of the COVID-19 pandemic, prompted rapid vaccine development. However, emerging variants challenge antibody-mediated protection. Targeting T-cell immunity is promising due to its crucial role in eliminating infected cells and the difficulty of viral evasion via HLA diversity. Despite this potential, there is a lack of HLA studies and SARS-CoV-2 epitope mapping in the I…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 24-032
cover
Validation Of Predicted Sars-cov-2 Nucleocapsid Protein Peptides (np104-122, …
Comment Share
Caroline Nadia Bahana

This study investigates the potential of T-cell-mediated immunity in combating SARS-CoV-2, given the concerns about the high mutation rate in the virus's S protein and its potential impact on vaccine efficacy. The prevalent HLA class II alleles in the Indonesian population, namely HLA-DRB1*12:02, HLA-DRB1*15:02, and HLA-DRB1*07:01, play a crucial role in presenting viral peptide antigens to the…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
EP BM-002